Literature DB >> 25592769

Risk factors for herpes zoster in a large cohort of unvaccinated older adults: a prospective cohort study.

B Liu1, A E Heywood1, J Reekie2, E Banks3, J M Kaldor2, P McIntyre4, A T Newall1, C R Macintyre1.   

Abstract

We analysed data from a prospective cohort of 255,024 adults aged ⩾45 years recruited from 2006-2009 to identify characteristics associated with a zoster diagnosis. Diagnoses were identified by linkage to pharmaceutical treatment and hospitalization records specific for zoster and hazard ratios were estimated. Over 940,583 person-years, 7771 participants had a zoster diagnosis; 253 (3·3%) were hospitalized. After adjusting for age and other factors, characteristics associated with zoster diagnoses included: having a recent immunosuppressive condition [adjusted hazard ratio (aHR) 1·58, 95% confidence interval (CI) 1·32-1·88], female sex (aHR 1·36, 95% CI 1·30-1·43), recent cancer diagnosis (aHR 1·35, 95% CI 1·24-1·46), and severe physical limitation vs. none (aHR 1·33, 95% CI 1·23-1·43). The relative risk of hospitalization for zoster was higher for those with an immunosuppressive condition (aHR 3·78, 95% CI 2·18-6·55), those with cancer (aHR 1·78, 95% CI 1·24-2·56) or with severe physical limitations (aHR 2·50, 95% CI 1·56-4·01). The novel finding of an increased risk of zoster diagnoses and hospitalizations in those with physical limitations should prompt evaluation of the use of zoster vaccine in this population.

Entities:  

Keywords:  Herpes zoster; prospective study; risk factors; shingles; vaccination

Mesh:

Year:  2015        PMID: 25592769      PMCID: PMC9151032          DOI: 10.1017/S0950268814003653

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  30 in total

Review 1.  Recommendations for the management of herpes zoster.

Authors:  Robert H Dworkin; Robert W Johnson; Judith Breuer; John W Gnann; Myron J Levin; Miroslav Backonja; Robert F Betts; Anne A Gershon; Maija L Haanpaa; Michael W McKendrick; Turo J Nurmikko; Anne Louise Oaklander; Michael N Oxman; Deborah Pavan-Langston; Karin L Petersen; Michael C Rowbotham; Kenneth E Schmader; Brett R Stacey; Stephen K Tyring; Albert J M van Wijck; Mark S Wallace; Sawko W Wassilew; Richard J Whitley
Journal:  Clin Infect Dis       Date:  2007-01-01       Impact factor: 9.079

2.  Hospitalizations to treat herpes zoster in older adults: causes and validated rates.

Authors:  Lisa A Jackson; Meredith A Reynolds; Rafael Harpaz
Journal:  Clin Infect Dis       Date:  2008-09-15       Impact factor: 9.079

3.  Comparing shingles incidence and complication rates from medical record review and administrative database estimates: how close are they?

Authors:  Barbara P Yawn; Peter Wollan; Jennifer St Sauver
Journal:  Am J Epidemiol       Date:  2011-09-13       Impact factor: 4.897

4.  The incidence of herpes zoster in a United States administrative database.

Authors:  Ralph P Insinga; Robbin F Itzler; James M Pellissier; Patricia Saddier; Alexander A Nikas
Journal:  J Gen Intern Med       Date:  2005-08       Impact factor: 5.128

5.  Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study.

Authors:  Sara L Thomas; Jeremy G Wheeler; Andrew J Hall
Journal:  Lancet       Date:  2002-08-31       Impact factor: 79.321

6.  Race and stress in the incidence of herpes zoster in older adults.

Authors:  K Schmader; L K George; B M Burchett; J D Hamilton; C F Pieper
Journal:  J Am Geriatr Soc       Date:  1998-08       Impact factor: 5.562

7.  A population based study of the epidemiology of Herpes Zoster and its complications.

Authors:  Dahlia Weitzman; Oren Shavit; Michal Stein; Raanan Cohen; Gabriel Chodick; Varda Shalev
Journal:  J Infect       Date:  2013-07-16       Impact factor: 6.072

8.  Use of hospitalization and pharmaceutical prescribing data to compare the prevaccination burden of varicella and herpes zoster in Australia.

Authors:  C R MacIntyre; C P Chu; M A Burgess
Journal:  Epidemiol Infect       Date:  2003-08       Impact factor: 2.451

9.  Cohort profile: the 45 and up study.

Authors:  Emily Banks; Sally Redman; Louisa Jorm; Bruce Armstrong; Adrian Bauman; John Beard; Valerie Beral; Julie Byles; Stephen Corbett; Robert Cumming; Mark Harris; Freddy Sitas; Wayne Smith; Lee Taylor; Sonia Wutzke; Sanja Lujic
Journal:  Int J Epidemiol       Date:  2007-09-19       Impact factor: 7.196

10.  Quantification of risk factors for herpes zoster: population based case-control study.

Authors:  Harriet J Forbes; Krishnan Bhaskaran; Sara L Thomas; Liam Smeeth; Tim Clayton; Sinéad M Langan
Journal:  BMJ       Date:  2014-05-13
View more
  10 in total

Review 1.  Sex and Gender Impact Immune Responses to Vaccines Among the Elderly.

Authors:  Ashley L Fink; Sabra L Klein
Journal:  Physiology (Bethesda)       Date:  2015-11

Review 2.  Prevention of Herpes Zoster and its complications: From clinical evidence to real life experience.

Authors:  Giovanni Gabutti; Paolo Bonanni; Michele Conversano; Guido Fanelli; Elisabetta Franco; Donato Greco; Giancarlo Icardi; Marzia Lazzari; Alessandro Rossi; Silvestro Scotti; Antonio Volpi
Journal:  Hum Vaccin Immunother       Date:  2016-12-07       Impact factor: 3.452

3.  Prevalence of and factors associated with herpes zoster in England: a cross-sectional analysis of the Health Survey for England.

Authors:  Sharon L Cadogan; Jennifer S Mindell; Judith Breuer; Andrew Hayward; Charlotte Warren-Gash
Journal:  BMC Infect Dis       Date:  2022-06-01       Impact factor: 3.667

4.  Herpes Zoster and Risk of Cancer in the Elderly U.S. Population.

Authors:  Parag Mahale; Elizabeth L Yanik; Eric A Engels
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-11-17       Impact factor: 4.254

Review 5.  Zeroing in on zoster: A tale of many disorders produced by one virus.

Authors:  Kristin M Galetta; Don Gilden
Journal:  J Neurol Sci       Date:  2015-10-03       Impact factor: 3.181

6.  A systematic literature review of herpes zoster incidence worldwide.

Authors:  Désirée van Oorschot; Hilde Vroling; Eveline Bunge; John Diaz-Decaro; Desmond Curran; Barbara Yawn
Journal:  Hum Vaccin Immunother       Date:  2021-03-02       Impact factor: 3.452

7.  Healthcare Resource Utilisation Associated with Herpes Zoster in a Prospective Cohort of Older Australian Adults.

Authors:  Surendra Karki; Anthony T Newall; C Raina MacIntyre; Anita E Heywood; Peter McIntyre; Emily Banks; Bette Liu
Journal:  PLoS One       Date:  2016-08-02       Impact factor: 3.240

8.  Herpes zoster risk after 21 specific cancers: population-based case-control study.

Authors:  Erik Hansson; Harriet J Forbes; Sinéad M Langan; Liam Smeeth; Krishnan Bhaskaran
Journal:  Br J Cancer       Date:  2017-05-02       Impact factor: 7.640

Review 9.  Risk Factors for Herpes Zoster Infection: A Meta-Analysis.

Authors:  Fawziah Marra; Kamalpreet Parhar; Bill Huang; Nirma Vadlamudi
Journal:  Open Forum Infect Dis       Date:  2020-01-09       Impact factor: 3.835

10.  Mood Disorders and Risk of Herpes Zoster in 2 Population-Based Case-Control Studies in Denmark and the United Kingdom.

Authors:  Sigrun A J Schmidt; Sinéad M Langan; Henrik S Pedersen; Henrik C Schønheyder; Sara L Thomas; Liam Smeeth; Kathryn E Mansfield; Henrik T Sørensen; Harriet J Forbes; Mogens Vestergaard
Journal:  Am J Epidemiol       Date:  2018-05-01       Impact factor: 4.897

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.